FindMyKOL
Clinical trialNCT01236768CompletedPhase 3Interventional

Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm

SponsorAgile TherapeuticsEnrollment407Contraception
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of the study is to evaluate the efficacy and safety of a low dose transdermal contraceptive delivery system containing ethinyl estradiol and levonorgestrel.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Facility name not stated

    Mobile, Alabama, United States

  • Facility name not stated

    Green Valley, Arizona, United States

  • Facility name not stated

    Tucson, Arizona, United States

  • Facility name not stated

    Los Angeles, California, United States

  • Facility name not stated

    Los Angeles, California, United States

  • Facility name not stated

    West Hills, California, United States

  • Facility name not stated

    Boynton Beach, Florida, United States

  • Facility name not stated

    South Miami, Florida, United States

  • Facility name not stated

    St. Petersburg, Florida, United States

  • Facility name not stated

    Newburgh, Indiana, United States

  • Facility name not stated

    Louisville, Kentucky, United States

  • Facility name not stated

    Las Vegas, Nevada, United States

  • Facility name not stated

    Las Vegas, Nevada, United States

  • Facility name not stated

    Kernersville, North Carolina, United States

  • Facility name not stated

    Englewood, Ohio, United States

  • Facility name not stated

    Tulsa, Oklahoma, United States

  • Facility name not stated

    Mt. Pleasant, South Carolina, United States

  • Facility name not stated

    Corpus Christi, Texas, United States

  • Facility name not stated

    Sugar Land, Texas, United States

  • Facility name not stated

    Newport News, Virginia, United States

  • Facility name not stated

    Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AG200-15Levora
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2010
Primary completion
30 Jun 2011
Completion
30 Jun 2011
Last update posted
15 Sept 2017
Registered enrollment
407
Registry id
NCT01236768

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.